Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative dexmedetomidine in neurosurgery patients
ChiCTR-IIR-17011924Phase 4Completed
- Sponsor
- Harbin Medical University Cancer Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in brain neoplasm (2 arms), sponsored by Harbin Medical University Cancer Hospital. Primary endpoints: endothelin, natural killer cell and 1 more. Started Jan 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on ChiCTR-IIR-17011924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17011924.